Erythromycin B

• Description :

  Erythromycin B has anti-malarial activity and effectively inhibits the asexual reproduction of Plasmodium falciparum[1].

• UNSPSC :

  12352005

• Hazard Statement :

  H319

• Target :

  Parasite

• Type :

  Natural Products

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/erythromycin-b.html

• Smiles :

  C[C@@H]([C@@H]([C@H](C(O[C@@H]([C@@H]([C@@H]([C@H](C([C@@H](C[C@]1(O)C)C)=O)C)O)C)CC)=O)C)O[C@H]2C[C@](C)([C@H]([C@@H](O2)C)O)OC)[C@H]1O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O

• Molecular Formula :

  C37H67NO12

• Molecular Weight :

  717.93

• Precautions :

  P264-P280-P305+P351+P338

• References & Citations :

  [1]Pranab K Bhadra, et al. Selected Derivatives of Erythromycin B- In Silico and Anti-Malarial Studies. Materials (Basel) . 2021 Nov 18;14 (22) :6980.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Natural Products

• Clinical Information :

  No Development Reported

• CAS Number :

  [527-75-3]